Trump Executive Order On Drug Pricing Is A Mixed Bag For Pharma
Fast Followers May Win Quicker Path To Approval
The order aims to eliminate the gap between small molecules and biologics in terms of the time to IRA-mandated Medicare negotiations, but pharma’s gain could be offset by other directives.
